S2Medical AB (publ) (S2M.ST)

SEK 0.01

(16.52%)

EBITDA Summary of S2Medical AB (publ)

S2Medical AB (publ)'s latest annual EBITDA in 2023 was -13.52 Million SEK , up 47.5% from previous year.
S2Medical AB (publ)'s latest quarterly EBITDA in 2024 Q2 was 7.27 Million SEK , up 529.52% from previous quarter.
S2Medical AB (publ) reported an annual EBITDA of -26.36 Million SEK in 2022, down -40.5% from previous year.
S2Medical AB (publ) reported an annual EBITDA of -18.72 Million SEK in 2021, down -34.42% from previous year.
S2Medical AB (publ) reported a quarterly EBITDA of 7.27 Million SEK for 2024 Q2, up 529.52% from previous quarter.
S2Medical AB (publ) reported a quarterly EBITDA of -4.14 Million SEK for 2023 Q1, up 36.44% from previous quarter.

Annual EBITDA Chart of S2Medical AB (publ) (2023 - 2015)

Historical Annual EBITDA of S2Medical AB (publ) (2023 - 2015)

Year	EBITDA	EBITDA Growth
2023	-13.52 Million SEK	47.5%
2022	-26.36 Million SEK	-40.5%
2021	-18.72 Million SEK	-34.42%
2020	-14.13 Million SEK	20.05%
2019	-17.45 Million SEK	-74.48%
2018	-9.78 Million SEK	-113.9%
2017	-4.57 Million SEK	-454.3%
2016	-825 Thousand SEK	-681.42%
2015	141.89 Thousand SEK	0.0%

Year	EBITDA	EBITDA Growth
2024 Q1	1.11 Million SEK	151.2%
2024 Q2	7.27 Million SEK	529.52%
2023 Q1	-4.14 Million SEK	36.44%
2023 FY	- SEK	42.92%
2023 Q3	-2.9 Million SEK	36.71%
2023 Q4	-2.36 Million SEK	18.61%
2023 Q2	-4.59 Million SEK	-10.92%
2022 Q2	-5.71 Million SEK	18.17%
2022 Q1	-6.98 Million SEK	-18.89%
2022 FY	- SEK	-40.5%
2022 Q4	-6.51 Million SEK	0.76%
2022 Q3	-6.56 Million SEK	-14.93%
2021 FY	- SEK	-34.42%
2021 Q1	-4.14 Million SEK	21.54%
2021 Q3	-4.56 Million SEK	-21.47%
2021 Q4	-5.87 Million SEK	-28.58%
2021 Q2	-3.75 Million SEK	9.33%
2020 FY	- SEK	20.05%
2020 Q3	-4.46 Million SEK	-1357.46%
2020 Q4	-5.28 Million SEK	-18.37%
2020 Q2	355 Thousand SEK	108.35%
2020 Q1	-4.25 Million SEK	22.16%
2019 Q2	-5.17 Million SEK	-47.27%
2019 Q1	-3.51 Million SEK	-2466.22%
2019 FY	- SEK	-74.48%
2019 Q4	-5.46 Million SEK	-86.97%
2019 Q3	-2.92 Million SEK	43.52%
2018 Q2	-2.16 Million SEK	5.76%
2018 FY	- SEK	-113.9%
2018 Q4	-136.85 Thousand SEK	97.13%
2018 Q3	-4.76 Million SEK	-120.56%
2018 Q1	-2.29 Million SEK	-86.34%
2017 Q2	-1.05 Million SEK	0.0%
2017 Q3	-1.23 Million SEK	-16.42%
2017 FY	- SEK	-454.3%
2017 Q1	-1.05 Million SEK	0.0%
2017 Q4	-1.23 Million SEK	0.0%
2016 FY	- SEK	-681.42%
2015 FY	- SEK	0.0%

Peer EBITDA Comparison of S2Medical AB (publ)

Name	EBITDA	EBITDA Difference
AddLife AB (publ)	1.54 Billion SEK	100.875%
Biotage AB (publ)	432 Million SEK	103.132%
Bonesupport Holding AB (publ)	28.93 Million SEK	146.754%
Doxa AB (publ)	296 Million SEK	104.571%
Elekta AB (publ)	3.29 Billion SEK	100.411%
iZafe Group AB (publ)	-15.61 Million SEK	13.369%
Ortivus AB (publ)	-14.92 Million SEK	9.359%
Ortivus AB (publ)	-14.92 Million SEK	9.359%
Q-linea AB (publ)	-210.98 Million SEK	93.588%
Synsam AB (publ)	1.71 Billion SEK	100.791%